1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Antimicrobial Ingredients Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Antimicrobial Ingredients Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Antimicrobial Ingredients Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Antibacterial Agents
6.3.2. Antifungal Agents
6.3.3. Antiviral Agents
6.3.4. Antiparasitic Agents
6.4. Market Attractiveness Analysis, by Product Type
7. Global Antimicrobial Ingredients Market Analysis and Forecast, by Form
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Form, 2017–2031
7.3.1. Dry
7.3.2. Liquid
7.4. Market Attractiveness Analysis, by Form
8. Global Antimicrobial Ingredients Market Analysis and Forecast, by End-use
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-use, 2017–2031
8.3.1. Skin Care Products
8.3.2. Hair Care Products
8.3.3. Oral Care Products
8.3.4. Make-up Products
8.3.5. Others
8.4. Market Attractiveness Analysis, by Form
9. Global Antimicrobial Ingredients Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Antimicrobial Ingredients Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2017–2031
10.3.1. Antibacterial Agents
10.3.2. Antifungal Agents
10.3.3. Antiviral Agents
10.3.4. Antiparasitic Agents
10.4. Market Value Forecast, by Form, 2017–2031
10.4.1. Dry
10.4.2. Liquid
10.5. Market Value Forecast, by End-use, 2017–2031
10.5.1. Skin Care Products
10.5.2. Hair Care Products
10.5.3. Oral Care Products
10.5.4. Make-up Products
10.5.5. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Form
10.7.3. By End-use
10.7.4. By Country
11. Europe Antimicrobial Ingredients Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2017–2031
11.3.1. Antibacterial Agents
11.3.2. Antifungal Agents
11.3.3. Antiviral Agents
11.3.4. Antiparasitic Agents
11.4. Market Value Forecast, by Form, 2017–2031
11.4.1. Dry
11.4.2. Liquid
11.5. Market Value Forecast, by End-use, 2017–2031
11.5.1. Skin Care Products
11.5.2. Hair Care Products
11.5.3. Oral Care Products
11.5.4. Make-up Products
11.5.5. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Form
11.7.3. By End-use
11.7.4. By Country/Sub-region
12. Asia Pacific Antimicrobial Ingredients Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2017–2031
12.3.1. Antibacterial Agents
12.3.2. Antifungal Agents
12.3.3. Antiviral Agents
12.3.4. Antiparasitic Agents
12.4. Market Value Forecast, by Form, 2017–2031
12.4.1. Dry
12.4.2. Liquid
12.5. Market Value Forecast, by End-use, 2017–2031
12.5.1. Skin Care Products
12.5.2. Hair Care Products
12.5.3. Oral Care Products
12.5.4. Make-up Products
12.5.5. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Form
12.7.3. By End-use
12.7.4. By Country/Sub-region
13. Latin America Antimicrobial Ingredients Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2017–2031
13.3.1. Antibacterial Agents
13.3.2. Antifungal Agents
13.3.3. Antiviral Agents
13.3.4. Antiparasitic Agents
13.4. Market Value Forecast, by Form, 2017–2031
13.4.1. Dry
13.4.2. Liquid
13.5. Market Value Forecast, by End-use, 2017–2031
13.5.1. Skin Care Products
13.5.2. Hair Care Products
13.5.3. Oral Care Products
13.5.4. Make-up Products
13.5.5. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Form
13.7.3. By End-use
13.7.4. By Country/Sub-region
14. Middle East & Africa Antimicrobial Ingredients Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2017–2031
14.3.1. Antibacterial Agents
14.3.2. Antifungal Agents
14.3.3. Antiviral Agents
14.3.4. Antiparasitic Agents
14.4. Market Value Forecast, by Form, 2017–2031
14.4.1. Dry
14.4.2. Liquid
14.5. Market Value Forecast, by End-use, 2017–2031
14.5.1. Skin Care Products
14.5.2. Hair Care Products
14.5.3. Oral Care Products
14.5.4. Make-up Products
14.5.5. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Form
14.7.3. By End-use
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Ashland Global Holdings Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. BASF SE
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Croda International Plc.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Lonza Group Ltd.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Clariant AG
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Dow
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Solvay SA
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Akzo Nobel N.V.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Wacker Chemie AG
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Evonik Industries AG
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
-gr.jpg)
